Rayonier Inc. (RYN): Today's Featured Conglomerates Winner

Rayonier was a winner within the conglomerates sector, rising $0.59 (1.0%) to $58.30 on light volume
By TheStreet Wire ,

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Rayonier

(

RYN

) pushed the Conglomerates sector higher today making it today's featured conglomerates winner. The sector as a whole was unchanged today. By the end of trading, Rayonier rose $0.59 (1.0%) to $58.30 on light volume. Throughout the day, 268,316 shares of Rayonier exchanged hands as compared to its average daily volume of 664,500 shares. The stock ranged in a price between $57.40-$58.35 after having opened the day at $57.85 as compared to the previous trading day's close of $57.71. Other companies within the Conglomerates sector that increased today were:

Tredegar Corporation

(

TG

), up 3.5%,

Dow Chemical

(

DOW

), up 1.8% and

Harbinger Group

(

HRG

), up 1.5%.

Rayonier, Inc. engages in the sale and development of real estate and timberland management, as well as in the production and sale of cellulose fibers in the United States, New Zealand, and Australia. Rayonier has a market cap of $7.4 billion and is part of the real estate industry. Shares are up 13.4% year to date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Rayonier a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

Rayonier

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front,

Pingtan Marine Enterprise

(

PME

), down 6.4%,

Capitol Acquisition Corp II

(

CLAC

), down 2.8% and

AcelRx Pharmaceuticals

(

ACRX

), down 1.6%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the conglomerates sector could consider

SPDR Trust Series 1

(

SPY

) while those bearish on the conglomerates sector could consider

ProShares Short S&P 500

(

SH

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

Loading ...